The contribution of PET/CT to improved patient management

被引:76
作者
Ell, PJ [1 ]
机构
[1] UCL, Inst Nucl Med, London, England
关键词
D O I
10.1259/bjr/18454286
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
With the introduction of both SPET/CT and PET/CT, multimodality imaging has truly entered routine clinical practice. Multiple slice spiral CT scanners have been incorporated with multiple detector gamma cameras or PET systems, such that the benefit of these modalities can be achieved in one patient sitting. The subject of this manuscript is PET/CT and its impact on patient management. Applications of PET/CT span the whole field of medical and surgical oncology since very few cancers do not take up the labelled glucose tracer, F-18-FDG. Given the contrast achieved, high-quality data can be obtained with FDG PET/CT. This technology has now spread worldwide and has been the subject of intense interest, as witnessed by the vast body of published evidence. In this short overview, only a brief discussion of the main clinical applications is possible. Novel applications of PET/CT outside the field of oncology are expected in the near future.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 45 条
[1]   Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology [J].
Antoch, G ;
Vogt, FM ;
Freudenberg, LS ;
Nazaradeh, F ;
Goehde, SC ;
Barkhausen, J ;
Dahmen, G ;
Bockisch, A ;
Debatin, JF ;
Ruehm, SG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (24) :3199-3206
[2]   FDG-PET for the pre-operative evaluation of colorectal liver metastases [J].
Arulampalam, THA ;
Francis, DL ;
Visvikis, D ;
Taylor, I ;
Ell, PJ .
EJSO, 2004, 30 (03) :286-291
[3]   Positron emission tomography and colorectal cancer [J].
Arulampalam, THA ;
Costa, DC ;
Loizidou, M ;
Visvikis, D ;
Ell, PJ ;
Taylor, I .
BRITISH JOURNAL OF SURGERY, 2001, 88 (02) :176-189
[4]   Clinical role of positron emission tomography in oncology [J].
Bomanji, J. B. ;
Costa, D. C. ;
Ell, P. J. .
LANCET ONCOLOGY, 2001, 2 (03) :157-164
[5]   Challenging cases and diagnostic dilemmas - Case 2. Pitfalls of positron emission tomography for assessing residual mediastinal mass after chemotherapy for Hodgkin's disease [J].
Bomanji, JB ;
Syed, R ;
Brock, C ;
Jankowska, P ;
Dogan, A ;
Costa, DC ;
Ell, PJ ;
Lee, SM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3347-3349
[6]  
Brücher BLDM, 2001, ANN SURG, V233, P300
[7]   Using "rationally designed drugs" rationally [J].
Brugarolas, J ;
Clark, JW ;
Chabner, B .
LANCET, 2003, 361 (9371) :1758-1759
[8]   The role of PET imaging in lymphoma [J].
Burton, C ;
Ell, P ;
Linch, D .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (06) :772-784
[9]  
Chung JK, 1999, J NUCL MED, V40, P986
[10]   Detection of bone metastases in breast cancer by 18FDG PET:: Differing metabolic activity in osteoblastic and osteolytic lesions [J].
Cook, GJ ;
Houston, S ;
Rubens, R ;
Maisey, MN ;
Fogelman, I .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3375-3379